The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Cyclopentyl-4-methyl-5-(2-((5-(4-(methylsulfonyl)piperazin-1-yl)pyridin-2-yl)amino)pyrimidin-4-yl)thiazol-2-amine ID: ALA4069886
PubChem CID: 135296342
Max Phase: Preclinical
Molecular Formula: C23H30N8O2S2
Molecular Weight: 514.68
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cn2)n1
Standard InChI: InChI=1S/C23H30N8O2S2/c1-16-21(34-23(26-16)27-17-5-3-4-6-17)19-9-10-24-22(28-19)29-20-8-7-18(15-25-20)30-11-13-31(14-12-30)35(2,32)33/h7-10,15,17H,3-6,11-14H2,1-2H3,(H,26,27)(H,24,25,28,29)
Standard InChI Key: ZIWFXQFVSGOWAZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
33.4194 -9.4527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8352 -10.1681 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.2467 -9.4502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1215 -10.5794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1169 -11.4044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4000 -11.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4093 -10.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6925 -10.5714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6880 -11.3964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9711 -11.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9666 -12.6299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2498 -13.0384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2590 -11.3884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5422 -11.7969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5377 -12.6219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8209 -13.0304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1012 -12.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3931 -13.0575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6725 -12.6560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6599 -11.8311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3680 -11.4077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3554 -10.5828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6807 -10.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9000 -10.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9236 -9.3197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7485 -9.3071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2232 -8.6323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8762 -7.8839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0667 -7.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9679 -6.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7164 -6.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2777 -7.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0154 -10.0878 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.0887 -11.8093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5490 -10.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
2 4 1 0
4 5 1 0
5 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
10 13 2 0
13 14 1 0
14 15 2 0
12 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
28 32 1 0
26 33 1 0
22 33 1 0
21 34 2 0
17 34 1 0
2 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.68Molecular Weight (Monoisotopic): 514.1933AlogP: 3.48#Rotatable Bonds: 7Polar Surface Area: 116.24Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.35CX Basic pKa: 3.63CX LogP: 2.55CX LogD: 2.55Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: -1.93
References 1. Tadesse S, Yu M, Mekonnen LB, Lam F, Islam S, Tomusange K, Rahaman MH, Noll B, Basnet SK, Teo T, Albrecht H, Milne R, Wang S.. (2017) Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation., 60 (5): [PMID:28156111 ] [10.1021/acs.jmedchem.6b01670 ]